L Fratiglioni, C Qiu - The Lancet Neurology, 2011 - thelancet.com
Less than two decades have passed since the first incidence data for Alzheimer's disease (AD) and other dementias were reported, during which there have been many achievements …
L Schneider - The Lancet Neurology, 2020 - thelancet.com
In Context estimated as about+ 1· 5 in ENGAGE and+ 1· 75 in EMERGE. Using the percentage differences relative to placebo (ie,–2% and+ 23%), the mean difference between …
CR Jack - The Lancet Neurology, 2022 - thelancet.com
Over the past two decades, the landscape of dementia research has changed drastically due to advances in knowledge at the molecular, cellular, animal, and human levels …
Summary At the First WHO Ministerial Conference on Global Action Against Dementia in March, 2015, 160 delegates, including representatives from 80 WHO Member States and …
RM Anderson, C Hadjichrysanthou, S Evans… - The Lancet, 2017 - thelancet.com
Alzheimer's disease is an irreversible, progressive brain disorder that accounts for about 50– 75% of all cases of dementia. 1 Alzheimer's disease is characterised by the presence of …
CM Mazure, J Swendsen - The Lancet Neurology, 2016 - thelancet.com
The Lancet Neurology Commission1 draws attention to the dramatically increasing personal, societal, and economic costs of Alzheimer's disease (AD) and associated …
N Schoenmaker, WA Van Gool - The Lancet Neurology, 2004 - thelancet.com
Summary The growing global disease burden attributable to dementia has strongly stimulated research activities. However, patients with dementia that are included in clinical …
Executive summary Acting now on dementia prevention, intervention, and care will vastly improve living and dying for individuals with dementia and their families, and in doing so …
Although the prevalence of dementia continues to increase worldwide, incidence in the western world might have decreased as a result of better vascular care and improved brain …